Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

Economists begin by asking what would happen in a completely free market. Then we ask whether government intervention of some ...

Experts said Trump’s action could lower the cost of prescription drugs, but they cautioned it's far from an immediate fix.

Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.

SaveHealth explores the distinctions between brand-name and generic drugs, outlines the financial advantages of generic ...

The Trump administration has put in motion its plan to secure lower prescription drug costs for Americans. This week, the ...

At CTO West Coast, an expert discussed the implications of the FDA’s expedited approval programmes with a spotlight on ...

A study by the Rand Corp., a nonpartisan research organization, found that, across all drugs, U.S. prices were 2.78 times as ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that ... and more accurate clinical trial periods. More data and faster analysis mean ...

A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic ...

Merck MRK and Pfizer PFE are leading pharmaceutical companies with strong product and pipeline portfolios in oncology. Both companies also have presences in vaccines, neuroscience, and immunology.

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company, today announced financial results for the first quarter ended March 31, 2025. Financial Results for the First Quarter ...